title: Retraction of cultured endothelial cell monolayer by human breast cancer cells, MCF-7.
abstract: A human breast cancer cell line (MCF-7), when sealed on confluent bovine pulmonary aortic endothelial cell (CPAE) monolayers, induced morphological changes (retraction) in CPAE cells. The area of retraction depended on the incubation time and the number of MCF-7 cells, suggesting that MCF-7 cells had the capacity to retract CPAE cells. This capacity was reduced by 60% by pretreatment of MCF-7 cells with 17 beta-estradiol (E) and progesterone (Pg). The extent of retraction was not affected by the addition of various protease inhibitors. CPAE retraction was induced also by adding conditioned medium (CM) from the culture of MCF-7 cells. Considerably less activity was detected in the CM obtained from MCF-7 cells cultured in the presence of E and Pg. The retraction was reversed in 24 h by culturing the monolayer in fresh medium without CM and was not induced by trypsin treatment of the CM.
authors.affiliation: Department of Tumor Biochemistry, Research Institute, Center for Adult Diseases, Osaka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yoshioka
authors.forename: M
authors.initials: M
authors.lastname: Mukai
authors.forename: K
authors.initials: K
authors.lastname: Shinkai
authors.forename: H
authors.initials: H
authors.lastname: Akedo
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002448:Cell Adhesion / Q000187:drug effects; D002450:Cell Communication / Q000502:physiology; D002460:Cell Line; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology* / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology; D006020:Glycopeptides / Q000494:pharmacology; D006023:Glycoproteins / Q000494:pharmacology; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D008858:Microscopy, Phase-Contrast; D011374:Progesterone / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D011980:Receptors, Progesterone / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology; D019714:Tissue Inhibitor of Metalloproteinases; D014357:Trypsin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D017077:Culture Media, Conditioned; D006020:Glycopeptides; D006023:Glycoproteins; D011480:Protease Inhibitors; D011980:Receptors, Progesterone; D019714:Tissue Inhibitor of Metalloproteinases; D013629:Tamoxifen; D011374:Progesterone; D004958:Estradiol; C032425:N-(N-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine; D017258:Medroxyprogesterone Acetate; D014357:Trypsin; D008666:Metalloendopeptidases; D007930:Leucine; C008890:phosphoramidon